NCT03830385View on ClinicalTrials.gov

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

PHASE2RecruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2026

Conditions
Squamous Cell Carcinoma Of The Head And Neck
Interventions
DRUG

PaclitaxelPaclitaxel (Albumin Bound),Bleomycin combined with Cisplatin or Carboplatin

All patients enrolled in the study will accept Paclitaxel (Albumin Bound),Bleomycin combined with Cisplatin or Carboplatin as their firstline chemotherapy

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER